• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    eBook
    Top Features
    Orthopedic Implants Are Fit to Print

    Fitting the Mold of Ortho Device Manufacturing

    Artificially Intelligent Design for Orthopedic Devices

    Shoulder Technology Isn't Made 'Off the Cuff'

    Instrument Manufacturing Leads Toward Smarter Surgeries
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Collagen Matrix Rebrands to Regenity Biosciences

    OsteoBoost Study Yields Positive Results

    Conventus Flower Ortho Appoints Jeff Culhane as COO

    Solid Growth Forecast for OTC Braces and Supports Market

    Exactech Boosts AI Expertise with Licensing Deal, Team of Scientists
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    ODT's Most-Read Stories This Week—March 25

    Switching Sterilization: What Should You Consider When Changing Processes?

    The MDR Delay’s Impact on Regulatory and Testing—An Orthopedic Innovators Q&A

    Navigating the EU MDR UDI Requirements: The Benefits and Challenges

    How 3D Printing is Impacting the Orthopedic Industry
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Enabling Technologies: The Future of Differentiation in Spinal Surgery

    Potential Applications of Continuous Carbon Fiber-Reinforced Additive Manufacturing

    X-Ray Sterilization Considered a 'Game-Changer' for Orthopedic Industry

    Medtech Firms Turning to Rigid Containers Amid Sterilization Wrap Shortage

    7 Ways Design Can Impact Orthopedic Manufacturing Costs
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Modern Plastics

    Life Science Outsourcing Inc.

    Braxton Manufacturing

    Tiodize

    AV&R
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • eBook
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Breaking News

    Biogennix Names Chief Financial Officer

    New hire has over 25 years of professional finance experience.

    Biogennix Names Chief Financial Officer
    Biogennix's osteoSPAN bone graft substitute is available in either granular form (1-4mm) or in blocks, called “Fusion Kits.” Image courtesy of Biogennix.
    Biogennix02.06.19
    Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft substitutes used for bone fusion procedures has named Robert Bazier its new chief financial officer. News of Baizer’s arrival comes on the heels of Biogennix reporting its 11,000th patient benchmark. 
     
    Baizer has over 25 years of professional finance experience, with the past 10 years focused specifically in the biotechnology sector. Most recently, he led a private equity group that partnered with Qualcomm Inc. to develop a suite of wireless medical devices. Prior to that, he formed and led an investment company that provided financing to emerging biotech companies during the financial crisis, which resulted in two portfolio companies becoming publicly traded. He started his finance career with TD Securities (USA) LLC, the investment bank and broker-dealer affiliate of Toronto-Dominion, where he worked from 1993 through 2008. Most recently, Baizer was the managing director responsible for TD’s U.S. derivatives business.  
     
    Baizer has an M.B.A. from Cornell University’s Johnson Graduate School of Management and a bachelor of science degree in electrical engineering from the University of California San Diego.
     
    “We are pleased to have Robert as a new key member of our Biogennix leadership team. Robert is a great fit and brings strong business, medical device and financial leadership experience to our team, further positioning us for continued growth,” said Michael Roux, Biogennix’s general manager. 
     
    In steady growth mode, Biogennix also has announced benchmark news that its products have now been used in more than 11,000 patients, a number that has increased by more than 5,000 patients since Q4 of 2017.  
     
    The company’s bone graft substitutes, osteoSPAN and Morpheus are resorbable, osteoconductive scaffolds ideally suited for bone regeneration and optimal handling by surgeons. Biogennix’s composites of calcium phosphate and calcium carbonate have complete interconnected porosity and the optimal pore diameter for bone reconstruction. Available in strips, granules and moldable putty, the products are indicated for orthopedic applications including the posterolateral spine, long bone and pelvis. 
     
    “We’re proud that our osteoSPAN and Morpheus bone graft products have been so well received by the clinician and patient communities and that we’ve been able to contribute to such positive post-op outcomes for more than 11,000 spine surgery patients,” said Clay Shors, Biogennix’s president. “We firmly believe that our products are fast becoming the new standard of effectiveness and ease of use when it comes to bone graft substitutes.” 
     
    The osteoSPAN bone graft substitute is available in either granular form (1-4mm) or in blocks, called “Fusion Kits.” The granules and blocks serve as bone graft substitutes and are mixable with autograft for use as a bone graft extender in the posterolateral spine.  Handling characteristics favored by surgeons include the product’s compressive strength, hydrophilicity, and easy integration with autogenous bone. 
     
    Morpheus is a moldable variation of the original osteoSPAN product. The 1-2mm osteoSPAN granules are combined with an organic binder which provides improved intraoperative handling and facilitates placement and containment of the implant. The binder dissolves quickly and does not interfere with the osteoconductive properties of the granules. The granules are gradually resorbed and remodeled by bone over the next six to 12 months.
     
    Biogennix designs, manufactures and distributes all of its products from its Irvine-based facilities.   
     
    Biogennix is a fully-integrated osteobiologic company headquartered in Irvine, Calif., that develops, manufactures, and distributes proprietary bone graft substitutes used in bone fusion procedures.
    Related Searches
    • reconstruction
    • surgery
    • bone regeneration
    • bone graft
    Suggested For You
    CartiHeal Enrolls Patients in Study of its Agili-C Cartilage Repair Implant CartiHeal Enrolls Patients in Study of its Agili-C Cartilage Repair Implant
    KCI Introduces Latest Advancement in Negative Pressure Wound Therapy for Multiple Traumatic Wounds KCI Introduces Latest Advancement in Negative Pressure Wound Therapy for Multiple Traumatic Wounds
    BIONIK Laboratories Launches Robotic System to Improve Stroke Rehab BIONIK Laboratories Launches Robotic System to Improve Stroke Rehab
    Implants Double the Rate of Bone Lengthening in Kids Implants Double the Rate of Bone Lengthening in Kids
    Nordic Capital Acquires Orchid Orthopedic Solutions Nordic Capital Acquires Orchid Orthopedic Solutions
    Nail Simplifies Two-Procedure Rotator Cuff Repair Nail Simplifies Two-Procedure Rotator Cuff Repair
    Material Matters: New Offerings for Orthopedic Technologies Material Matters: New Offerings for Orthopedic Technologies
    SYNOSTE Raises €5.1M to Launch Smart Skeletal Deformation Correction Tech SYNOSTE Raises €5.1M to Launch Smart Skeletal Deformation Correction Tech
    Testing in a Rapidly Changing World Testing in a Rapidly Changing World
    Ortho Regenerative Technologies Appoints New CFO Ortho Regenerative Technologies Appoints New CFO
    First Positive Results of Biodegradable Tibia Implant Tests Announced First Positive Results of Biodegradable Tibia Implant Tests Announced
    Simulations Reveal Role of Calcium in Titanium Implant Acceptance Simulations Reveal Role of Calcium in Titanium Implant Acceptance
    Ortho Regenerative Technologies Announces CFO Change Ortho Regenerative Technologies Announces CFO Change
    1. Stryker Corp. 1. Stryker Corp.
    2. DePuy Synthes 2. DePuy Synthes

    Related Breaking News

    • Large Joint
      CartiHeal Enrolls Patients in Study of its Agili-C Cartilage Repair Implant

      CartiHeal Enrolls Patients in Study of its Agili-C Cartilage Repair Implant

      The product is designed to help patients with knee-cartilage defects to regenerate their own healthy cartilage.
      PR Newswire 02.06.19

    • KCI Introduces Latest Advancement in Negative Pressure Wound Therapy for Multiple Traumatic Wounds

      KCI Introduces Latest Advancement in Negative Pressure Wound Therapy for Multiple Traumatic Wounds

      The V.A.C.RX4 System is the result of a collaboration between KCI and the U.S. military.
      Business Wire 01.28.19

    • Extremities | MIS/Robotics | Trauma/Sports
      BIONIK Laboratories Launches Robotic System to Improve Stroke Rehab

      BIONIK Laboratories Launches Robotic System to Improve Stroke Rehab

      InMotion ARM/HAND robotic system is for clinical rehabilitation of stroke survivors and those with mobility impairments due to neurological conditions.
      Business Wire 01.23.19


    • Implants Double the Rate of Bone Lengthening in Kids

      Implants Double the Rate of Bone Lengthening in Kids

      Russian scientists developed advanced implants for the Ilizarov orthopedic system.
      Tomsk Polytechnic University 01.23.19

    • Contract Manufacturing
      Nordic Capital Acquires Orchid Orthopedic Solutions

      Nordic Capital Acquires Orchid Orthopedic Solutions

      Nordic Capital to acquire controlling majority holding in Orchid, with Altor retaining a significant minority holding.
      Nordic Capital 01.22.19

    Loading, Please Wait..

    Trending
    • Missouri Neurosurgeon Settles Federal Kickback Lawsuit For $825K
    • Enabling Technologies: The Future Of Differentiation In Spinal Surgery
    • Össur Unveils Rebound ACL Brace
    • Spinal Stabilization Technologies Begins LOPAIN2 Trial In South America
    • AAOS News: Mark S. Myerson Receives 2023 Humanitarian Award
    Breaking News
    • Report: No Complications With OssDsign Catalyst Graft
    • FDA OKs Bioretec's RemeOs Bioresorbable Metal Trauma Screw
    • First Clinical Use of Stryker’s Tornier Pyrocarbon Humeral Head
    • CoreLink's Siber Ti 3D-Printed SI Joint Fusion System Earns FDA Nod
    • Collagen Matrix Rebrands to Regenity Biosciences
    View Breaking News >
    CURRENT ISSUE

    March/April 2023

    • Fitting the Mold of Ortho Device Manufacturing
    • Artificially Intelligent Design for Medical Devices
    • Orthopedic Implants Are Fit to Print
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kemin Human Nutrition & Health Acquires Oral Health Ingredient
    Wiley Eliminates Outer Carton From Packaging to Reduce Waste
    ACG Expands as Vantage Nutrition Acquires ComboCap and its Dual-Chamber Capsule Technology
    Coatings World

    Latest Breaking News From Coatings World

    PPG Names Rodolfo Ramirez GM, Packaging Coatings
    Sherwin-Williams Unveils High Performance Interior Marine Decking Systems
    AkzoNobel Appoints Ricardo Rosso as Pontiac Site Manager
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease
    Aural Analytics' Speech Analytics Software for ALS Gains Breakthrough Status
    Bigfoot Biomedical Acquires Insulin Titration Algorithm from McGill
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Thermo Fisher, Arsenal Biosciences Partner to Manufacture Autologous T-Cell Therapies
    Aquestive Therapeutics Expands Libervant License/Supply Agreement with Pharmanovia
    OncoVent, Orient EuroPharma Enter License Agreement for Oregovomab
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    GK Launches Vegan Hair Styling Range
    Sexual Wellness Brand Playground Recruits Christina Aguilera
    Buttah Skin Founder Wins Emerging Brand Partner of the Year Award from Macy’s
    Happi

    Latest Breaking News From Happi

    Ichimaru Pharcos Launches New Anti-Aging Ingredient ‘HyaluGuard’
    Indie Personal Care and Skincare Brand Indigo Wild Mainstreams Geranium-Patchouli Scent
    Kao Launches Space Shampoo Sheet for Haircare
    Ink World

    Latest Breaking News From Ink World

    INX International Makes Investment in Gooten
    Videojet Launches 1580 C Soft-Pigmented Contrast Printer
    Epson to Showcase Textile, Signage and Aqueous Printers at ISA 2023
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    AWA announces first International Linerless Label Conference
    Apex partners with MicroDynamics for anilox quality control
    Industrias Omega adds Durst Tau RSC E
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Toray Awarded for Nanodesign Technology
    SharpCell Launches Plastic-free Airlaid Material for Premium Napkins
    Suominen Offers Biolace Ultrasoft
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Collagen Matrix Rebrands to Regenity Biosciences
    OsteoBoost Study Yields Positive Results
    Conventus Flower Ortho Appoints Jeff Culhane as COO
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Universal Display Sponsors, Presents at ICDT 2023
    Miron Washington Joins Impinj Board of Directors
    All-Time High for Global 300MM Semiconductor Capacity in 2026: SEMI

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login